Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 529 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Hearing Disorders and Deafness Clear all
Not listed Not applicable Interventional

Evaluation of Hearing Protection Fit Testing Program

NCT02109757
View directory record Official record
Conditions
Hearing Loss
Interventions
Software intervention and education, Education only
Other
Lead sponsor
United States Air Force
Federal
Eligibility
Not listed
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2014
U.S. locations
2
States / cities
Elemendorf Air Force Base, Alaska • Dayton, Ohio
Source: ClinicalTrials.gov public record
Updated Apr 10, 2014 · Synced Oct 21, 2026, 1:36 AM EDT
Enrolling by invitation Not applicable Interventional

Hearing Health Equity Through Accessible Research and Solutions for Korean Americans

NCT06803394
View directory record Official record
Conditions
Age-related Hearing Impairment, Personal Communication, Hearing Impairment, Hearing Loss, Community-dwelling Seniors, Korean
Interventions
K-HEARS Intervention, K-HEARS Sound Amplifier Intervention
Behavioral · Device
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older
Enrollment
800 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2028
U.S. locations
1
States / cities
Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Mar 12, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Active, not recruiting Phase 2 Interventional

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

NCT06627179
View directory record Official record
Conditions
Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind, Retinal Disease, Eye Diseases, Hereditary, Eye Disorders Congenital, Vision Disorders
Interventions
Intravitreal Injection of Ultevursen, No intervention, will not receive any active study intervention
Drug · Other
Lead sponsor
Laboratoires Thea
Industry
Eligibility
8 Years and older
Enrollment
81 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2028
U.S. locations
10
States / cities
San Francisco, California • Miami, Florida • Atlanta, Georgia + 7 more
Source: ClinicalTrials.gov public record
Updated Jul 9, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Active, not recruiting Not applicable Interventional

Expanded Indications in the Pediatric BONEBRIDGE Population

NCT05615649
View directory record Official record
Conditions
Hearing Loss, Conductive, Hearing Loss, Mixed
Interventions
MED-EL BONEBRIDGE Bone Conduction Implant
Device
Lead sponsor
Med-El Corporation
Industry
Eligibility
3 Years to 12 Years
Enrollment
36 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
6
States / cities
Aurora, Colorado • Miami, Florida • Newark, New Jersey + 3 more
Source: ClinicalTrials.gov public record
Updated Aug 19, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Recruiting No phase listed Observational

Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array

NCT06936449
View directory record Official record
Conditions
Sensorineural Hearing Loss, Bilateral Hearing Loss
Interventions
CI632D, CI632
Device
Lead sponsor
Cochlear
Industry
Eligibility
18 Years and older
Enrollment
19 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2028
U.S. locations
3
States / cities
Englewood, Colorado • Iowa City, Iowa • Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Jul 7, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Recruiting Not applicable Interventional

Hearing Impairment, Strategies and Outcomes in VA Emergency Departments

NCT05028972
View directory record Official record
Conditions
Hearing Loss, Emergency Service, Hospital Readmission
Interventions
Personal Amplifier, No Personal Amplifier
Other
Lead sponsor
VA Office of Research and Development
Federal
Eligibility
60 Years and older
Enrollment
1,050 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2027
U.S. locations
6
States / cities
Aurora, Colorado • New York, New York • Syracuse, New York + 3 more
Source: ClinicalTrials.gov public record
Updated Oct 5, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Terminated Phase 2Phase 3 Interventional Results available

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

NCT05158296
View directory record Official record
Conditions
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind, Retinal Disease, Eye Diseases, Eye Diseases, Hereditary, Eye Disorders Congenital, Vision Disorders
Interventions
Ultevursen, Sham-procedure
Drug · Other
Lead sponsor
Laboratoires Thea
Industry
Eligibility
12 Years and older
Enrollment
7 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
10
States / cities
San Diego, California • San Francisco, California • Miami, Florida + 7 more
Source: ClinicalTrials.gov public record
Updated Jul 12, 2024 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Direct-to-Consumer Hearing Aids and Listening Effort

NCT05855005
View directory record Official record
Conditions
Hearing Loss, Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Interventions
DTC Hearing Aids
Device
Lead sponsor
Northwestern University
Other
Eligibility
18 Years to 90 Years
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
2
States / cities
Chicago, Illinois • Evanston, Illinois
Source: ClinicalTrials.gov public record
Updated May 29, 2024 · Synced Oct 21, 2026, 1:36 AM EDT
Completed No phase listed Observational

Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures

NCT06421766
View directory record Official record
Conditions
Hearing Loss
Interventions
BAHS
Device
Lead sponsor
Oticon Medical
Industry
Eligibility
19 Years and older
Enrollment
234 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024
U.S. locations
1
States / cities
Birmingham, Alabama
Source: ClinicalTrials.gov public record
Updated Jul 31, 2025 · Synced Oct 21, 2026, 1:36 AM EDT
Terminated No phase listed Observational Accepts healthy volunteers

Cochlear Implant Speech and Non-speech Sound Recognition

NCT03661970
View directory record Official record
Conditions
Deafness, Sound Perception, Quality of Sound
Interventions
Cognate Speech Synthesizer sound percepts
Other
Lead sponsor
Pacific Northwest University of Health Sciences
Other
Eligibility
18 Years and older
Enrollment
10 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2023
U.S. locations
1
States / cities
Kennewick, Washington
Source: ClinicalTrials.gov public record
Updated Feb 20, 2024 · Synced Oct 21, 2026, 1:36 AM EDT
Recruiting Not applicable Interventional

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

NCT07039435
View directory record Official record
Conditions
Sensorineural Hearing Loss, Cochlear Implantation, Perceptual Adaptation
Interventions
Alternative Frequency Mapping
Other
Lead sponsor
NYU Langone Health
Other
Eligibility
18 Years and older
Enrollment
22 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2029
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jul 7, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional Results available

Post-market Study to Capture Information Regarding Performance of Lyric2

NCT01861704
View directory record Official record
Conditions
Hearing Loss
Interventions
Lyric, Lyric2
Device
Lead sponsor
Phonak AG, Switzerland
Industry
Eligibility
18 Years to 90 Years
Enrollment
177 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
1
States / cities
Newark, California
Source: ClinicalTrials.gov public record
Updated May 19, 2014 · Synced Oct 21, 2026, 1:36 AM EDT
Recruiting Phase 1Phase 2 Interventional

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

NCT07304024
View directory record Official record
Conditions
Central Auditory Processing Disorder, Hearing Impaired (Partially), Hearing, Hearing Abnormality, Hearing Disability, Hearing Disorder, Hearing Disorders, Hearing Impairment, Sensorineural, Hearing Handicap, Hearing Impaired, Hearing Impairment, Hearing Loss, Central Auditory Disease, Noise Exposure, Noise Induced Hearing Loss, Noise-Induced Hearing Loss, Sound Perception, Myelin Degeneration, Myelinopathy, Myelin Integrity, Remyelination, Hidden Hearing Loss, Cocktail Party Skill, Cocktail Party Syndrome, CAPD, Age Problem
Interventions
Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound, Placebo - Placebo
Combination Product · Drug
Lead sponsor
University of Colorado, Denver
Other
Eligibility
45 Years to 65 Years
Enrollment
344 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2028
U.S. locations
1
States / cities
Aurora, Colorado
Source: ClinicalTrials.gov public record
Updated Apr 30, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional Results available

The Performance-Perceptual Test as a Counseling Tool

NCT00126113
View directory record Official record
Conditions
Hearing Impairment
Interventions
PPT-based Counseling, Standard Educational Counseling
Behavioral
Lead sponsor
US Department of Veterans Affairs
Federal
Eligibility
45 Years to 65 Years
Enrollment
74 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2008
U.S. locations
1
States / cities
Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Oct 16, 2014 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Phase 2 Interventional

OTO-104 for the Treatment of Meniere's Disease

NCT01412177
View directory record Official record
Conditions
Meniere's Disease
Interventions
OTO-104, Placebo
Drug
Lead sponsor
Otonomy, Inc.
Industry
Eligibility
18 Years to 80 Years
Enrollment
154 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
2
States / cities
San Diego, California • Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Sep 3, 2015 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional

A Pediatric Comparison of Remote Microphone Technologies

NCT06564701
View directory record Official record
Conditions
Hearing Loss
Interventions
Phonak Roger TouchScreen Microphone, Phonak Partner Mic
Device
Lead sponsor
Sonova AG
Industry
Eligibility
8 Years to 12 Years
Enrollment
25 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
1
States / cities
Oklahoma City, Oklahoma
Source: ClinicalTrials.gov public record
Updated Mar 13, 2025 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Phase 2 Interventional Results available

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

NCT01649869
View directory record Official record
Conditions
Cytomegalovirus Infection
Interventions
Placebo, Valganciclovir
Other · Drug
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eligibility
1 Month to 4 Years
Enrollment
54 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2019
U.S. locations
9
States / cities
Birmingham, Alabama • Washington D.C., District of Columbia • St Louis, Missouri + 6 more
Source: ClinicalTrials.gov public record
Updated Oct 16, 2024 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Reducing Childhood Hearing Loss in an Alaska Native Population Through a New School Screening and Referral Process That Utilizes Mobile Health and Telemedicine

NCT03309553
View directory record Official record
Conditions
Hearing Loss
Interventions
Current Primary Care Referral Process, Telemedicine Referral Process
Other
Lead sponsor
Norton Sound Health Corporation
Other
Eligibility
4 Years to 21 Years
Enrollment
1,481 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2020
U.S. locations
1
States / cities
Nome, Alaska
Source: ClinicalTrials.gov public record
Updated Jun 16, 2020 · Synced Oct 21, 2026, 1:36 AM EDT
Suspended Phase 1Phase 2 Interventional

Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss

NCT02616172
View directory record Official record
Conditions
Sensorineural Hearing Loss
Interventions
Autologous Bone Marrow Infusion
Genetic
Lead sponsor
James Baumgartner, MD
Other
Eligibility
2 Years to 6 Years
Enrollment
10 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2022
U.S. locations
1
States / cities
Orlando, Florida
Source: ClinicalTrials.gov public record
Updated Mar 18, 2022 · Synced Oct 21, 2026, 1:36 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss.

NCT02082431
View directory record Official record
Conditions
Sensorineural Hearing Loss, Long QT Syndrome
Interventions
Not listed
Lead sponsor
Pediatrix
Other
Eligibility
1 Day to 90 Days
Enrollment
600 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2020
U.S. locations
12
States / cities
Anchorage, Alaska • Phoenix, Arizona • Waterford, Connecticut + 6 more
Source: ClinicalTrials.gov public record
Updated Oct 5, 2020 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Phase 1 Interventional

Outcomes In Children With Developmental Delay And Deafness

NCT01256229
View directory record Official record
Conditions
Deafness, Hearing Loss
Interventions
cochlear implantation, hearing aids
Device
Lead sponsor
Stanford University
Other
Eligibility
1 Day to 5 Years
Enrollment
303 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2016
U.S. locations
2
States / cities
Stanford, California • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Nov 15, 2016 · Synced Oct 21, 2026, 1:36 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

iotaSOFT Pediatric Study

NCT06106373
View directory record Official record
Conditions
Hearing Loss, Sensorineural, Hearing Loss, Bilateral, Hearing Loss, Unilateral
Interventions
iotaSOFT Insertion System
Device
Lead sponsor
iotaMotion, Inc.
Industry
Eligibility
9 Months to 12 Years
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2025
U.S. locations
2
States / cities
Iowa City, Iowa • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Aug 6, 2026 · Synced Oct 21, 2026, 1:36 AM EDT
Terminated Not applicable Interventional

Percutaneous Cochlear Implantation: Implementation of Technique

NCT01460823
View directory record Official record
Conditions
Hearing Loss
Interventions
Percutaneous Cochlear Implantation using image guided surgical techniques
Procedure
Lead sponsor
Vanderbilt University
Other
Eligibility
18 Years to 80 Years
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2014
U.S. locations
1
States / cities
Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Dec 16, 2014 · Synced Oct 21, 2026, 1:36 AM EDT
Recruiting Not applicable Interventional

Barriers and Facilitators to OTC Hearing Aids Success

NCT06499805
View directory record Official record
Conditions
Hearing Loss, Sensorineural, Presbycusis
Interventions
Audiologist-based fitting, Over-the-counter fitting
Device
Lead sponsor
Yu-Hsiang Wu
Other
Eligibility
18 Years to 89 Years
Enrollment
360 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2029
U.S. locations
2
States / cities
Iowa City, Iowa • Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated May 21, 2025 · Synced Oct 21, 2026, 1:36 AM EDT